More precisely, the HLA class II allele HLA-DRB1*15:01 increases the risk of MS (OR = 3.92), whereas the HLA class I allele HLA-A*02:01 has protective effects (OR = 0.67) [119,120]. Here, HLA-DRB1 is linked to myeloid sarcoma.